Dennis Dimo Enkelmann

Title: Dennis Dimo Enkelmann: Innovator in Pharmaceutical Co-Crystals

Introduction

Dennis Dimo Enkelmann is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on co-crystals. His research focuses on improving the efficacy of medications, which can have a profound impact on patient care.

Latest Patents

Enkelmann holds a patent for "Co-crystals comprising levothyroxine and a dicarboxylic acid." This invention relates to co-crystals that include levothyroxine and a dicarboxylic acid, such as L-tartaric acid or oxalic acid. The patent outlines processes for preparing these co-crystals and describes a pharmaceutical composition that can be used as a medicament, particularly for treating hypothyroidism. This innovation is crucial for enhancing the delivery and effectiveness of the medication.

Career Highlights

Dennis Dimo Enkelmann is associated with Sandoz AG, a global leader in generic pharmaceuticals. His work at Sandoz has allowed him to focus on developing advanced pharmaceutical formulations that can improve patient outcomes. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Enkelmann has collaborated with esteemed colleagues, including Marijan Stefinovic and Ulrich Griesser. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical science.

Conclusion

Dennis Dimo Enkelmann's contributions to the field of pharmaceuticals, particularly through his patent on co-crystals, highlight his commitment to improving medication efficacy. His work at Sandoz AG and collaborations with fellow researchers underscore the importance of teamwork in driving innovation.